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Abstract
Background: Carbapenemase-producing Enterobacteriaceae (CPE) pose a considerable threat to modern medicine.
New treatment options and methods to limit spread need to be investigated. Blue light (BL) is intrinsically
antimicrobial, and we have previously demonstrated significant antimicrobial effects on biofilms of a panel of
isolates, including two CPEs.
This study was performed to assess the antibacterial activity of 405 nm BL against a panel of CPE isolates (four
encoding blaNDM, three blaKPC, two blaOXA-48, and three encoding both NDM and OXA-48 carbapenemases).
Methods: In vitro experiments were conducted on 72 h old biofilms of CPEs which were exposed to 60 mW/cm2 of
BL. Changes to biofilm seeding were assessed by measuring the optical density of treated and untreated biofilms.
Results: Twelve bacterial clinical isolates (comprising eight Klebsiella pnemoniae, one K. oxytoca, and three
Escherichia coli) were tested. BL was delivered for 5, 15 and 30 min, achieving doses of 162, 54, and 108 J/cm2,
respectively.
All of the CPEs were susceptible to BL treatment, with increasing reductions in seeding with increasing durations of
exposure. At 30 min, reductions in biofilm seeding of ≥80% were observed for 11 of the 12 isolates, compared to
five of 12 after 15 min. CPE_8180 was less susceptible than the rest, with a maximum reduction in seeding of 66%
at 30 min.
Conclusions: BL is effective at reducing the seeding of mature CPE biofilms in vitro, and offers great promise as a
topical decontamination/treatment agent for both clinical and environmental applications.
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Background
Infections caused by multidrug-resistant organisms and
other nosocomial pathogens are associated with in-
creased morbidity and mortality, and are estimated to
cost the UK National Health Service >£1 billion a year
[1]. Enterobacteriaceae are a common cause of commu-
nity- and hospital-acquired infections, and are becoming
increasingly multiresistant to first- and second-line
antibiotics [2]. Carbapenemase-producing Enterobacteri-
aceae (CPE) are a particular concern, and have evolved
due to the Enterobacteriacae group acquiring transfer-
able β-lactamases which have recently evolved to confer
resistance to the carbapenem (as well as penicillin and
cephalosporin) classes of antibiotics. Treatment options
for CPEs are severely restricted, and hence the rapid
global increase and spread of CPEs has become a public
health crisis, threatening delivery of healthcare and
patient safety [3].
The UK reported a large increase in the number of
CPE isolates from 2008 to 2013 [4, 5], and there have
been a number of outbreaks reported both in the UK
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and in Europe [5]. In England, most known CPE trans-
mission occurs in hospitals, and consequently various
key guidance documents exist on the management of
colonisation or infection due to CPE in England [6] in
order to prevent or reduce their spread into (and within)
healthcare settings. These advocate a range of precau-
tions including the rapid identification of CPE-colonised
patients, isolation (and barrier nursing) to prevent
onward transmission, adherence to hand hygiene guide-
lines, and stringent cleaning and decontamination of
patient bed spaces and equipment to ensure that there is
no risk to other patients or staff members.
Despite greater awareness of the importance of envir-
onmental decontamination for reducing HAI risk, clean-
ing can often be inefficient especially in busy and
understaffed wards [7]. Several authors have investigated
novel technologies for whole room decontamination (in-
cluding ultraviolet (UV) light [8, 9], hydrogen peroxide
vapour (HPV) [8], and ozone [10]) that could be used to
supplement the standard cleaning protocols for CPEs
and other HAIs. These technologies all have broad anti-
microbial activity, with UV treatment of rooms spiked
with a range of nosocomial pathogens resulting in 2–4
log10 reductions in bacterial counts [11]. These tech-
nologies have a major disadvantage in that rooms need
to be sealed and unoccupied at the time of application.
The blue wavelengths within the visible light spectrum
(especially wavelengths between 400 nm to 470 nm) are
intrinsically antimicrobial and do not require additional
exogenous photosensitizers to exert an antimicrobial effect
[12]. Photodynamic inactivation of bacterial cells occurs
due to photo-excitation of intracellular porphyrins [13] by
the blue light (BL), leading to energy transfer and the
production of highly cytotoxic reactive oxygen species
(ROS); primarily singlet oxygen (1O2) [12, 14–16]. Although
less germicidal compared to ultra-violet light [13], patho-
gens can be selectively inactivated whilst preserving human
cells and consequently BL is considered much less detri-
mental to mammalian cells [17, 18].
BL has been shown to exhibit a broad spectrum of
antimicrobial effect against bacteria and fungi [19–21], and
has been investigated as a new disinfection technology
termed the HINS-light environmental decontamination
system (HINS-EDS) [13, 22–24]. The HINS-EDS is a type
of ceiling-mounted lightbulb which delivers low-irradiance
405 nm light continuously and is suitable for use in patient
occupied settings. Evaluation studies showed that there was
a statistically significant 90% reduction in numbers of
culturable Staphylococci spp. following 24 h of use in an
unoccupied room [22], and reductions of 56–86% when
used in burns isolation rooms occupied by MRSA-positive
patients. Furthermore, when the system was no longer
used, the room became recontaminated to levels similar to
those pre-treatment.
This study was performed to investigate whether 405
nm blue light is effective against CPEs in the in vitro
setting. Given that the majority of environmental con-
tamination involves bacteria growing/persisting as
biofilms, coupled with the higher tolerance of biofilms
to decontamination agents, we investigated the effects of
BL on mature biofilms.
Methods
A series of in vitro experiments were conducted with a
panel of organisms (Table 1) to determine the efficacy of
blue light (405 nm) against CPE bacteria growing as
Table 1 The characteristics (species, source, resistance mechanism, and antibiogram) of the CPE isolates
Study
identifier
Bacterium Source Resistance
mechanisma
Antibiogram
AMO AUG TAZ CXM CEO CET CAZ CPM AZT ERT MER AMI CIP CLX
CPE_8180 K. pneumoniae Groin swab blaNDM R R R R R R R R R R R S R R
CPE_8770 K. pneumoniae Drain blaNDM R R R R R R R R R R R S R R
CPE_9606 E. coli Tip of cannula blaNDM R R R R R R R R R R R S R R
CPE_7534 E. coli Wound blaNDM R R R R R R R R R R R S R R
CPE_5773 K. pneumoniae Faeces blaNDM & blaOXA-48 R R R R R R R R R R R R R R
CPE_6949 K. pneumoniae Urine blaKPC R R R R R R R I R R R S S R
CPE_0257 K. pneumoniae Urine blaKPC R R R R R R R R R R R S I R
CPE_4388 K. oxytoca Sputum blaKPC R R R R R R R I R R R S S R
CPE_1798 K. pneumoniae Urine blaOXA-48 R R R R R R R R R R I S R R
CPE_8421 E. coli Drain blaOXA-48 R nt R R R R R R R R R S S nt
CPE_9956 K. pneumoniae Urine blaNDM and blaOXA-48 R R R R R R R R R R R R R R
CPE_7855 K. pneumoniae Urine blaNDM and blaOXA-48 R R R R R R R R R R R S R R
Notes: a as determined through PCR testing at reference laboratory Antibiogram: R (resistant), I (intermediate), S (sensitive), nt (not tested). AMO (Amoxicillin), AUG
(Augmentin), TAZ (Piperacillin tazobactam), CXM (Cefuroxime), CEO (Cefoxitin), CET (Cefotaxime), CAZ (Ceftazidime), CPM (Cefepime), AZT (Aztreonam), ERT
(Ertapenem), MER (Meropenem), AMI (Amikacin), CIP (Ciprofloxacin), CLX (Cephalexin)
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mature biofilms. The panel comprised 12 well-charac-
terised clinical CPE isolates recovered from clinical sam-
ples at the Queen Elizabeth Hospital in Birmingham. All
isolates were highly antibiotic resistant and were recov-
ered from a variety of sources. Typing using a discrimin-
atory approach (e.g. variable number tandem repeat
(VNTR) for Klebsiella spp., and multi-locus sequence
typing (MLST) for both Klebsiella spp. and E.coli) was
performed by relevant reference laboratories for all iso-
lates prior to inclusion in the study.
All isolates were stored at − 80 °C on Protect™ beads,
and were routinely cultured on cysteine lactose electro-
lyte deficient (CLED) or blood agar prior to each experi-
ment. Experiments were designed to assess the
antibacterial activity of blue light against biofilm growth
forms of the panel of bacteria described above.
Blue light equipment
High intensity blue light was provided by a LED (light
emitting diode) Flood array (Henkel-Loctite, Hemel
Hempstead, UK). This array utilises 144 reflectorized
LEDs which produce a homogeneous illuminated area of
10 cm× 10 cm. The emission spectrum of the LED array
was determined using a USB2000 spectrophotometer
(Ocean Optics, Oxford, UK), and the platform calibrated
to deliver a reproducible irradiance of 60mW/cm2 when
the LED array was positioned 15.5 cm above the test area.
Impact of blue light on pre-formed biofilms
The antibacterial activity of blue light against pre-formed
biofilms was assessed by conducting ‘minimum biofilm
eradication concentration’ (MBEC) experiments [25] on
each isolate (Fig. 1). Overnight LB cultures of the test
strains (made by inoculating approximately three to five
colonies into 5ml of fresh Luria Broth (LB) broth and
incubating at 37 °C overnight) were diluted in fresh
antibiotic-free Mueller-Hinton (MH) broth to an optical
density (OD) at 600 nm of 0.1 and then 200 μl seeded into
wells of a 96-well microtiter tray (MTT). Positive (200 μl
0.1 OD600 diluted organisms) and negative (200 μl MH
broth) controls were included per blue light time point to
be tested.
To produce a ‘transferable biofilm’, a 96 well polypro-
pylene plate [Starlabs, UK] was then placed into the
MTT so that each well contained a ‘peg’, on which bio-
films could form, before the plates were sealed, and stat-
ically incubated at 33 °C for 72 h. After 72 h, the pegs
(±biofilm) were removed and washed in a MTT contain-
ing sterile water (to remove any unbound cells). The
positive and negative control ‘peg plate’ was placed in a
clean, empty MTT and wrapped in foil. Following this,
both the control and the test peg plate were placed in
the test area (15.5.cm beneath the light source) and ex-
posed to the blue light for time points of 15 or 30 min
(corresponding to a blue light dose of 54 or 108 J/cm2
respectively). Shorter BL exposures were also performed
by reducing the distance between the array and the light
source, so that a 5 min exposure delivered the same dose
of BL as a 45min exposure (162 J/cm2).
The foil around the control plate prevented the pegs
from receiving any blue light treatment (and hence these
positive control biofilms were not exposed to the blue
Fig. 1 Flow diagram showing the stages of the MBEC assay
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light), but the control plate biofilms would have most
likely been exposed to the same amount of heating and
drying as the blue light exposed test plate.
After the treatment, the peg plates were carefully
placed into a MTT containing 200 μl sterile MH broth
(herein referred to as ‘reporter broth’) for overnight
incubation. After 18-24 h, the OD of the reporter broth
was measured to assess the viability (seeding) of the bio-
films following blue light exposure.
To demonstrate the presence of biofilms on the pegs,
crystal violet (CV) assays were additionally performed
on the pegs after the OD of the reporter broth had been
measured. This involved placing the pegs into MTTs
containing 200 μl of 1% CV (which binds to any present
microbial biomass of biofilm), followed by washing (to
remove unbound CV) and subsequent solubilisation of
the CV in 200 μl of 70% ethanol. The peg biofilm
biomass could then be measured using OD readings as
previously and the presence of the biofilm confirmed.
Two biological and 10 technical replicates were
performed for each strain and blue light exposure
duration, respectively.
The blue light dose (J/cm2) received by the bacteria
was calculated by multiplying the irradiance of light (W/
cm2) to which the sample was exposed, by the exposure
time (seconds).
Statistical analysis
The ability of biofilms to seed new growth following ex-
posure to blue light was assessed by comparing the OD
values at each blue light time point (5, 15, and 30 min)
versus the untreated (positive) control. An initial check
of the data using ggplot2 [26] demonstrated that the
data were non-normal in distribution (data not shown),
and consequently the non-parametric Mann-Whitney U
test was used to determine significance (p < 0.05) and
produce estimates of the median of the difference
between sets of OD values, along with 95% confidence
intervals. The software package R [27] (version 3.4.3)
was used for all analysis.
Results
All isolates were confirmed to be genetically diverse and
unrelated via typing (VNTR and MLST) (Additional file 1:
Tables S1, S2 and Additional file 2: Figure S1 and Add-
itional file 3: Figure S2), and hence were included in the
study. All were susceptible to BL treatment, with statisti-
cally significant (p < 0.05) reductions in biofilm seeding (of
72 h biofilms) observed when compared to an untreated
positive control. There was no significant difference in the
seeding of the positive controls across all time points (data
not shown), and all isolates (apart from CPE_8180) were
similarly susceptible. In contrast to previously published
data [28], there were no isolates where BL treatment
resulted in increased biofilm seeding.
A time-dependent effect was noticed, with longer
exposure times resulting in greater reductions in seeding
(Fig. 2). For example, at five minutes exposure, ≥80%
reductions in seeding were observed for two isolates
(CPE_5773 and CPE_9606), compared to five isolates at
15 min (CPE_5773, CPE_7855, CPE_0257, CPE_8770
and CPE_9606), and 11 isolates at 30 min (all except for
CPE_8180) (Table 2).
Interestingly there was not a dose-dependent effect of
BL. Although the dose of BL was modified so that it was
higher at 5 min (162 J/cm2) than at 15 or 30mins (doses
of 54 J/cm2 and 108 J/cm2, respectively), this is not
reflected in the results, with the smallest reductions in
seeding observed at five minutes for the majority of
isolates (11/12) (Table 2). At this dosage, reductions in
seeding ranged from 13.9% (CPE_8180) to 89.8%
(CPE_4388).
BL treatment of the mature CPE biofilms also had
anti-biofilm effects, with reductions in biofilm biomass
observed for all isolates when the CV data for the
exposed biofilm was compared to the unexposed positive
control (Additional file 4: Figure S3).
Discussion
Environmental contamination of a range of hospital sur-
faces is recognised as a source of patient infection, and
improved cleaning and disinfection methods are
continually being sought. Various studies [22–24]
have shown the effectiveness of a ceiling-mounted
405 nm light system (the HINS-light EDS) for con-
tinuous decontamination of the air and all exposed
surfaces within the environment. This system emits
405 nm BL at an irradiance of 0.1–0.5 mW/cm2 [13],
and has undergone numerous clinical evaluations
within in-patient and out-patient settings as men-
tioned previously. However, to our knowledge, no
studies exist which examine the effectiveness of this
wavelength of BL against multidrug resistant organ-
isms, including CPEs.
We have shown in this small study that 405 nm BL is
universally effective against a small panel of genetically
diverse CPEs, achieving equal reductions in seeding of
mature biofilms, regardless of antibiotic susceptibility or
antibiotic resistance mechanisms carried by the specific
isolates. All results were statistically significant (p <
0.05), and in contrast to our previous work [28], there
were no increases in biofilm seeding in response to BL
(which we previously hypothesised was the result of
sub-lethal BL stress of the isolates concerned). We also
found concurrent reductions in biofilm biomass, demon-
strating that BL has anti-biofilm effects, as well as effect-
ively reducing seeding.
Halstead et al. Antimicrobial Resistance and Infection Control            (2019) 8:14 Page 4 of 8
There is evidence of reduced susceptibility in one K.
pneumoniae blaNDM CPE isolate (CPE_8180), with mod-
est reductions in seeding (of 66.1%) after 30 min BL
exposure. There were reductions of 90.9% with a similar
K. pneumoniae blaNDM CPE isolate (CPE_8770) after the
same exposure time and dose, and this difference cannot
be explained by antibiogram since both isolates had
identical susceptibilities (Table 1). Porphyrins are
reported to be key for the mechanism of action (MOA)
of BL [14, 20], however recent work has demonstrated
that viruses (that lack porphyrins) are also susceptible
[29]. Feline calicivirus (FCV) was used as a surrogate for
norovirus, and exposed to 405 nm BL whilst suspended
in minimal, and organically-rich media. A plaque assay
performed to assess how the virus infectivity changed
following BL exposure, revealed a 4 log10 (99.99%)
reduction in infectivity of FCV in minimal media after a
dose of 2.8 KJ/cm2 [29, 30]. Interestingly, there was
enhanced inactivation when FCV was present in the
organically-rich media [29]. The molecular basis of BL
susceptibility would be an interesting avenue to investi-
gate further, both to ascertain why CPE_8180 had lower
susceptibility, and to further elucidate the MOA.
There are various limitations of this work. Owing to
time constraints, we only tested a small panel of 12 CPE
producers, and these were restricted to blaNDM, blaOXA-48
and blaKPC, produced by Klebsiella pneumoniae, K. oxy-
toca and E. coli. To make this work more applicable, it
would be useful to additionally test isolates producing bla-
VIM and blaIMP, as these are also important carbapene-
mases globally. Although we have tested BL against a
number of A. baumannii previously [28], we could also
Fig. 2 Showing the mean average biofilm seeding for all isolates following testing with blue light
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have included pan-resistant species in this current study
(such as blaOXA positive A. baumannii), and acknowledge
this as a limitation.
For simplicity, all experiments were performed on
monomicrobial biofilms growing on a polystyrene plastic
surface. To ensure that results are applicable to the clin-
ical setting, experiments should be performed on a range
of materials present in the clinical setting (e.g. metals,
wood, plastics, painted surfaces), to account for any dif-
ferences in biofilm formation or absorption of BL. Also,
it would be prudent to investigate whether BL remains
effective when biofilms contain a variety of species of
bacteria and/or viruses. Also, to conform to standard
tests of decontamination, we would need to measure
what a 90% reduction (for example) means in terms of
log10 reductions, and perform tests comparing this tech-
nology to conventional cleaning measures to ensure
non-inferiority of BL, and see whether there is an addi-
tive effect.
In terms of translating this technology, the BL array
would need to be incorporated into a suitable delivery
platform, either a light fitting or ‘robot’ (for decontamin-
ation of a room or clinical setting) or a hand held
device/wand. The latter would be of most use for the
decontamination of small areas, but could also be
explored further for superficial wound decontamination/
treatment. This would require collaboration with indus-
trial partners and extensive additional testing. The
potential for bacteria to develop resistance to BL would
also need to be investigated once a prototype platform
has been developed.
It is hypothesised that tolerance is unlikely owing to
the non-selective nature of the MOA and resulting
ROS-damage [31], but there were conflicting results
from a number of studies [32, 33]. Tomb et al. [30, 34]
repeatedly exposed MSSA and MRSA isolates to
sub-lethal doses of BL (108 J/cm2 chosen since it
resulted in 98% inactivation in previous studies) for 15
cycles, and enumerated surviving colonies after each
cycle. These counts were assessed over the 15 cycles and
no statistically significant differences were identified,
suggesting that sub-lethal BL doses do not promote
bacterial tolerance. This further supports BL as a prom-
ising new agent for clinical decontamination.
Conclusions
We have shown in this small study that BL is effective at
reducing the seeding of mature CPE biofilms in vitro,
and offers great promise as a topical decontamination/
treatment agent for both clinical and environmental
applications. Further research is warranted to investigate
activity on polymicrobial biofilms existing on a range of
other clinically relevant materials and to develop a
suitable prototype for clinical translation of this promis-
ing technology.
Additional files
Additional file 1: Table S1: Showing the VNTR profiles and MLST types
(where available) for the Klebsiella pneumoniae and K. oxytoca isolates
used in the study. Table S2: Showing the MLST types (where available)
for the Escherichia coli isolates used in the study. (DOCX 17 kb)
Table 2 The percentage reductions in biofilm seeding following testing with the three doses of BL
Study
identifier
Bacterium Resistance
mechanism^
Percentage (%) reductions in biofilm seeding following BL exposure
5 min (162 J/cm2) 15 min (54 J/cm2) 30 min (108 J/cm2)
% reduction n p-value % reduction n p-value % reduction n p-value
CPE_8180 K. pneumoniae blaNDM 13.9 20 < 0.0001 15.9 40 < 0.0001 66.1 40 < 0.0001
CPE_8770 K. pneumoniae blaNDM 88.1 20 < 0.0001 89.0 40 < 0.0001 90.9 40 < 0.0001
CPE_9606 E. coli blaNDM 66.7 20 < 0.0001 93.0 40 < 0.0001 91.8 40 < 0.0001
CPE_7534 E. coli blaNDM 54.2 40 < 0.0001 76.3 40 < 0.0001 89.1 40 < 0.0001
CPE_5773 K. pneumoniae blaNDM & blaOXA-48 64.7 20 < 0.0001 81.9 40 < 0.0001 94.6 40 < 0.0001
CPE_6949 K. pneumoniae blaKPC 32.5 20 0.0023 47.7 40 < 0.0001 87.7 40 < 0.0001
CPE_0257 K. pneumoniae blaKPC 34.8 20 < 0.0001 82.9 40 < 0.0001 83.4 40 < 0.0001
CPE_4388 K. oxytoca blaKPC 89.8 20 < 0.0001 79.8 40 < 0.0001 91.2 40 < 0.0001
CPE_1798 K. pneumoniae blaOXA-48 20.6 20 0.0202 74.3 40 < 0.0001 85.5 40 < 0.0001
CPE_8421 E. coli blaOXA-48 28.9 40 0.0044 68.3 40 < 0.0001 82.9 40 < 0.0001
CPE_9956 K. pneumoniae blaNDM & blaOXA-48 31.0 20 < 0.0001 40.0 40 < 0.0001 96.7 40 < 0.0001
CPE_7855 K. pneumoniae blaNDM & blaOXA-48 26.3 20 0.0015 87.9 40 < 0.0001 97.7 40 < 0.0001
Notes: Resistance mechanism: ^ as determined through PCR testing at reference laboratory. blaNDM (gene encoding for New Delhi metallo-beta-lactamase 1),
blaKPC (gene encoding for Klebsiella pneumoniae carbapenemase), blaOXA-48 (gene encoding oxacillinase OXA-48)
Bold numbers represent results where there was ≥80% reductions in biofilm seeding
‘n’ refers to the number of technical replicates that were performed
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Additional file 2: Figure S1: Core phylogeny tree showing the
relatedness of the seven Klebsiella pneumoniae isolates that were
included in the study. (PDF 278 kb)
Additional file 3: Figure S2: Core phylogeny tree showing the
relatedness of the three Escherichia coli isolates that were included in the
study. (PDF 254 kb)
Additional file 4: Figure S3: showing the mean average biofilm
biomass for all isolates following testing with blue light. (PDF 182 kb)
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